IHC of paraffin-embedded Carcinoma of Human thyroid tissue using anti-TSC22D1 mouse monoclonal antibody.
IHC of paraffin-embedded Human pancreas tissue using anti-TSC22D1 mouse monoclonal antibody.
IHC of paraffin-embedded Human tonsil using anti-TSC22D1 mouse monoclonal antibody.
IHC of paraffin-embedded Carcinoma of Human prostate tissue using anti-TSC22D1 mouse monoclonal antibody.
IHC of paraffin-embedded Human prostate tissue using anti-TSC22D1 mouse monoclonal antibody.
IHC of paraffin-embedded Adenocarcinoma of Human endometrium tissue using anti-TSC22D1 mouse monoclonal antibody.
IHC of paraffin-embedded Carcinoma of Human liver tissue using anti-TSC22D1 mouse monoclonal antibody.
IHC of paraffin-embedded Adenocarcinoma of Human colon tissue using anti-TSC22D1 mouse monoclonal antibody.
IHC of paraffin-embedded Human breast tissue using anti-TSC22D1 mouse monoclonal antibody.
IHC of paraffin-embedded Adenocarcinoma of Human ovary tissue using anti-TSC22D1 mouse monoclonal antibody.
IHC of paraffin-embedded Human liver tissue using anti-TSC22D1 mouse monoclonal antibody.
IHC of paraffin-embedded Carcinoma of Human kidney tissue using anti-TSC22D1 mouse monoclonal antibody.
IHC of paraffin-embedded Human Kidney tissue using anti-TSC22D1 mouse monoclonal antibody.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY TSC22D1 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-TSC22D1.
Flow cytometry of Jurkat cells, using anti-TSC22D1 antibody (Red), compared to a nonspecific negative control antibody (Blue).
Flow cytometry of HeLa cells, using anti-TSC22D1 antibody (Red), compared to a nonspecific negative control antibody (Blue).